en
Scientific article
English

Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting

Published inJournal of rheumatology, vol. 38, no. 3, p. 567-571
Publication date2011
Abstract

Psoriasis is often associated with other diseases, substantially adding to the patient's burden of disease. Recent epidemiologic studies have demonstrated an increased cardiovascular morbidity among patients with psoriasis and psoriatic arthritis (PsA), which contributes to their reduced life expectancy. At the meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) adjacent to the International Federation of Psoriasis Associations (IFPA) congress, members discussed the pathogenetic aspects of this association and resulting consequences for the management of patients with psoriasis and PsA. A future research agenda was considered.

Keywords
  • Arthritis, Psoriatic/*epidemiology/pathology
  • Cardiovascular Diseases/*epidemiology
  • Comorbidity
  • *Congresses as Topic
  • Female
  • Humans
  • Male
  • Psoriasis/*epidemiology/pathology
  • Sweden
Affiliation Not a UNIGE publication
Citation (ISO format)
BOEHNCKE, Wolf-Henning, GLADMAN, Dafna D., CHANDRAN, Vinod. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting. In: Journal of rheumatology, 2011, vol. 38, n° 3, p. 567–571. doi: 10.3899/jrheum.101124
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal0315-162X
549views
0downloads

Technical informations

Creation09/20/2013 4:48:57 PM
First validation09/20/2013 4:48:57 PM
Update time03/14/2023 8:26:10 PM
Status update03/14/2023 8:26:09 PM
Last indexation02/12/2024 8:34:03 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack